Paper6722005
Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody.
Gordon J and 4 others. Br J Cancer, 1984. Cited by 36 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody. Papers, record 6722005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6722005
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Immunization, Passive | Major topic |
| Immunoglobulin Idiotypes | Major topic |
| Leukemia, Lymphoid | Major topic |
| Aged | |
| Cells, Cultured | |
| Complement System Proteins | |
| Cytotoxicity, Immunologic | |
| Female | |
| Humans | |
| Immunization Schedule | |
| Immunoglobulin G | |
| Leukocyte Count | |
| Male | |
| Middle Aged |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,192,162 | An antigen density effect on the hemolytic efficiency of complement. | J Immunol | 1970 | https://conductscience.org/library/papers/4192162 | PubMed |
| 2 | 4,115,135 | Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. | J Exp Med | 1972 | https://conductscience.org/library/papers/4115135 | PubMed |
| 3 | 4,137,136 | Prolymphocytic leukaemia. | Br J Haematol | 1974 | https://conductscience.org/library/papers/4137136 | PubMed |
| 4 | 4,610,077 | Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes. | J Exp Med | 1974 | https://conductscience.org/library/papers/4610077 | PubMed |
| 5 | 4,140,238 | Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4140238 | PubMed |
| 6 | 47,617 | Antibody to a molecularly-defined antigen confined to a tumour cell surface. | Nature | 1975 | https://conductscience.org/library/papers/47617 | PubMed |
| 7 | 49,376 | The specificity of a solid phase radioimmunoassay for human immunoglobulins. | J Immunol Methods | 1975 | https://conductscience.org/library/papers/49376 | PubMed |
| 8 | 52,924 | Immunological suppression of idiotypic specificities. | Transplant Rev | 1975 | https://conductscience.org/library/papers/52924 | PubMed |
| 9 | 1,085,341 | Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. | J Exp Med | 1976 | https://conductscience.org/library/papers/1085341 | PubMed |
| 10 | 62,018 | Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. | J Exp Med | 1976 | https://conductscience.org/library/papers/62018 | PubMed |
| 11 | 69,552 | Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. | Fed Proc | 1977 | https://conductscience.org/library/papers/69552 | PubMed |
| 12 | 415,966 | Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. | Immunology | 1977 | https://conductscience.org/library/papers/415966 | PubMed |
| 13 | 418,499 | Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells. | Scand J Immunol | 1978 | https://conductscience.org/library/papers/418499 | PubMed |
| 14 | 82,581 | Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. | J Immunol | 1978 | https://conductscience.org/library/papers/82581 | PubMed |
| 15 | 94,899 | BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. | Immunol Rev | 1979 | https://conductscience.org/library/papers/94899 | PubMed |
| 16 | 6,997,386 | Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. | J Immunol | 1980 | https://conductscience.org/library/papers/6997386 | PubMed |
| 17 | 7,427,932 | Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. | Cancer Res | 1980 | https://conductscience.org/library/papers/7427932 | PubMed |
| 18 | 7,192,154 | Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7192154 | PubMed |
| 19 | 6,969,771 | Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. | J Exp Med | 1980 | https://conductscience.org/library/papers/6969771 | PubMed |
| 20 | 6,970,171 | Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen. | Immunology | 1981 | https://conductscience.org/library/papers/6970171 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11,368,285 | Achieving optimal outcomes in chronic lymphocytic leukaemia. | Drugs | 2001 | https://conductscience.org/library/papers/11368285 | PubMed |
| 2,440,795 | Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel. | Immunology | 1987 | https://conductscience.org/library/papers/2440795 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6722005
GET https://conductscience.org/api/papers/v1/6722005/references?page=2